Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
Clinical trial NCT00565968 · COMPLETED
Trial details
- NCT number
- NCT00565968
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.